Small Peptides Targeting Lactate Dehydrogenase-A
This technology presents engineered peptide inhibitors designed to selectively block lactate dehydrogenase A (LDHA) activity, offering a novel therapeutic approach for diseases characterized by elevated LDHA, such as cancer and metabolic disorders.
Background:
Lactate dehydrogenase A (LDHA) is an enzyme that plays a key role in cellular metabolism...
Published: 6/12/2026
|
Inventor(s): Mehdi Mollapour, Gennady Bratslavsky, Mark Woodford
Keywords(s): FLCN, lactate dehydrogenase, metabolic switch, tumor suppressor, Warburg effect
Category(s): Campus > Upstate Medical University
|